Source: Research Seminar 2005 - Adaptations to Hypoxia
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Voelkel (Denver, Co, United States Of America). Pulmonary vascular remodeling and stem cells. Research Seminar 2005 - Adaptations to Hypoxia

Member's Comments

No comment yet.

Related content which might interest you: Plasticity of vascular progenitor cells: implications in pulmonary vascular remodeling in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 803s Year: 2006 Plasticity of vascular progenitor cells: Implications in pulmonary vascular remodelling in COPD Source: Eur Respir Rev 2006; 15: 209-210 Year: 2006 Mast cells promote lung vascular remodelling in pulmonary hypertension Source: Eur Respir J 2011; 37: 1400-1410 Year: 2011 Investigation of the participation of bone marrow derived cells in pulmonary angiogenesis and vascular remodeling Source: Eur Respir J 2002; 20: Suppl. 38, 481s Year: 2002 Nestin-expressing vascular wall cells drive development of pulmonary hypertension Source: Eur Respir J 2016; 47: 876-888 Year: 2016 IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Source: Eur Respir J, 56 (4) 2003167; 10.1183/13993003.03167-2020 Year: 2020 Vascular remodelling is reversed following BMPR2 modified endothelial progenitor cell therapy in a MCT-induced PAH rat model Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Distinct patterns of circulating endothelial cells in pulmonary hypertension Source: Eur Respir J 2010; 36: 1284-1293 Year: 2010 PDGFRa and aSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Role of mast cells and chymase in pulmonary vascular remodeling Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Role of progenitor cells in lung vascular repair: A novel approach for the treatment of pulmonary hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Role of endothelial and smooth muscle cells in vascular wall remodeling of large pulmonary arteries in patients with CTEPH Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Source: Eur Respir Monogr 2021; 91: 290-305 Year: 2021 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma Source: Eur Respir J 2011; 38: 679-687 Year: 2011